Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CDXS · against 102 other Healthcare companies of similar size
Ranked #75 of 103 · scores higher than 26% of peers
Bars: peers in each 10-point band of the growth score12 peers with a growth score of 20–29, including CDXS · Click a bar to see the companies
Mainly because of its 3-year revenue growth, which is weaker than most Healthcare peers.
| Metric | CDXS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 110 reported | 18.6% | 4.9% | 73% | 33% | |
| Earnings per share growthHigher is better · 38 reported | Not reported | -0.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 101 reported | -20.2% | 3.0% | 10% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 1 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 90M USD | 99 | 27 | |
| 1 | 649M SEK (≈$65M) | 99 | 29 | |
| 71 | 1.4B HKD (≈$180M) | 26 | 61 | |
| 71 | 227M USD | 26 | 24 | |
| 73 | 172.4B KRW (≈$124M) | 24 | 26 | |
| 73 | 144.4B KRW (≈$104M) | 24 | 56 | |
| 75 | 118M USD | 23 | 13 | |
| 75 | 79M EUR (≈$87M) | 23 | 25 | |
| 77 | 131M CAD (≈$96M) | 22 | 40 | |
| 77 | 213M EUR (≈$235M) | 22 | 40 | |
| 79 | 1.0B MYR (≈$229M) | 20 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score